Prices delayed by at least 15 minutes | Print
Lantheus Holdings (LNTH)
Common SharesThis share can be held in a Dealing accountISALifetime ISAJISASIPP
Company profile
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
Address
331 Treble Cove Road
North Billerica
MA
USA
01862
Telephone
+1 978 671-8001
Forecast key dates
Name | Key Date |
---|---|
Lantheus Holdings Inc First Quarter Earnings Conference Call for 2025 | 2025-05-02T08:00:00 |
Lantheus Holdings Inc First Quarter Earnings Results for 2025 | 2025-05-02T00:00:00 |
Lantheus Holdings Inc Annual General Meeting for 2025 | 2025-04-25T10:30:00 |
Lantheus Holdings Inc Fourth Quarter Earnings Conference Call for 2024 | 2025-02-21T08:00:00 |
Lantheus Holdings Inc Fourth Quarter Earnings Results for 2024 | 2025-02-21T00:00:00 |
Lantheus Holdings Inc Annual Report for 2024 | 2025-02-21T00:00:00 |
Lantheus Holdings Inc Third Quarter Earnings Conference Call for 2024 | 2024-11-01T08:00:00 |
Lantheus Holdings Inc Third Quarter Earnings Results for 2024 | 2024-11-01T00:00:00 |
Lantheus Holdings Inc Second Quarter Earnings Conference Call for 2024 | 2024-08-02T08:00:00 |
Lantheus Holdings Inc Second Quarter Earnings Results for 2024 | 2024-08-02T00:00:00 |
Lantheus Holdings Inc First Quarter Earnings Conference Call for 2024 | 2024-05-02T08:00:00 |
Lantheus Holdings Inc First Quarter Earnings Result for 2024 | 2024-05-02T00:00:00 |
Previous key dates
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.